Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Alliance Witan PLC - Net Asset Value
-
Coherent Appoints Sherri Luther as Chief Financial Officer
-
Coherent Appoints Sherri Luther as Chief Financial Officer
-
Bitget Launches Telegram App Centre, Featuring Over 600 TON Trending Mini-Apps
-
Main Street Financial Services Corp. Declares Quarterly Dividend
-
Helene Shifts HOMB into Hurricane Mode
-
Celestica Launches the DS4100, its Latest 800G Switch Optimized for AI/ML Data Center Workloads
-
23andMe Announces 1-for-20 Reverse Stock Split
-
Ocean Power Technologies to Present at the MicroCap Rodeo Fall Conference in New York City on October 16th, 2024
-
Royalty Pharma Declares Fourth Quarter 2024 Dividend
-
XYZ Media Introduces a New Season of ‘Next Generation of Innovators' Series with David Wu's Innovative Project: Detecting Plant Stress and Phenotyping in Live California Crops Using Therma
-
XYZ Media Introduces a New Season of ‘Next Generation of Innovators' Series with David Wu's Innovative Project: Detecting Plant Stress and Phenotyping in Live California Crops Using Thermal Imaging
-
MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024
-
Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis for Second Consecutive Year
-
Alignment Healthcare Continues to Deliver High-Quality Medicare Advantage Plans, 4 Stars or Greater for 98% of Members in 2025
-
Media Advisory: MADD Canada Presents New School Program for Manitoba Students
-
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
-
InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference
-
GYL Financial Synergies Named to Forbes 2024 Top RIA Firms List
-
Par Pacific Announces Third Quarter 2024 Earnings Release and Conference Call Schedule
-
Hurco's AI Innovations Set to Revolutionize the Industry, Ushering in a New Era of Speed and Precision
-
Global Uranium Corp. Prepares to Commence Ground-Based Radiometric Survey on Wyoming Projects
-
Somnia’s New “World Builder” Gives Creators Tools To Make Games and Virtual Experiences Easily
-
Acrivon Therapeutics Announces Initial Patient Dosing in Phase 1 Trial of ACR-2316, a Novel WEE1/PKMYT1 Inhibitor Designed Using AP3 for Superior Single-Agent Activity
-
Paltalk Holdings Announces Judge Enters Final Judgment in Connection With Cisco Jury Verdict
-
Nano Labs Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
-
FangDD Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
SAIHEAT Announces Receipt of Notification from Nasdaq
-
InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference
-
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Michelin : Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Auron Announces Poster Presentation at 2024 PCF Annual Scientific Retreat
-
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
-
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
-
Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx Health
-
Gate.io Will List PUFFER for Trading and Simultaneously Launch PUFFER Mining, with a Total Amount of 1,500,000 Tokens
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE GOLD 3X DAILY SHORT SECURITIES ISIN: IE00B6X4BP29
-
Man Group PLC : Form 8.3 - AngloGold Ashanti plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
-
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
-
U.S. Energy Corp. Regains Full Compliance with Nasdaq Listing Standards
-
AGBA ADVANCES TOWARD COMPLETION OF THE TRILLER MERGER
-
Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology
-
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
-
OTC Markets Group Welcomes Concord Acquisition Corp II to OTCQX
-
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024
-
Acquisition of The Sempre Group Holdings Ltd
